Testing minocycline for brain bleeding recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You had a brain CT scan showing a spontaneous bleed in the upper part of the brain (not caused by injury or other condition).
- The bleed size is between 15 and 40 ml on the CT scan.
- Your symptoms started within the last 48 hours.
- You have a moderate to severe stroke (NIHSS score 8 to 24) and are awake enough to follow commands.
- You or your legal representative can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the antibiotic minocycline can help people recover from a brain bleed (intracerebral hemorrhage). It is for adults who had a moderate to severe stroke, were independent before, and can start treatment within 24 hours.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial studies how certain proteins in the blood affect brain inflammation after a small brain bleed (intracerebral hemorrhage). It aims to find new ways to reduce inflammation and improve recovery.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.